Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-049394

Chief Business Officer sold 6,943 shares at $39.15 ($271,796)

  • Chief Business Officer acquired 6,943 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Parrish Jay · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-01 Exercise or conversion : show line 1 in the form +6,943 $1.58 $10,935 229,165 D
2020-09-01 Sale : show line 2 in the form −6,943 $39.15 $271,796 222,222 D
Open-market sales · 6,943 sh · avg $39.15 · $271,796

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-09-01 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −6,943 53,241 D
Loading xslF345X03/doc4.xml…